Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 1
2018 3
2019 2
2020 3
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
New and Old Hot Drug Targets in Tuberculosis.
Chiarelli LR, Mori G, Esposito M, Orena BS, Pasca MR. Chiarelli LR, et al. Among authors: orena bs. Curr Med Chem. 2016;23(33):3813-3846. doi: 10.2174/1389557516666160831164925. Curr Med Chem. 2016. PMID: 27666933 Review.
Shifts of Faecal Microbiota During Sporadic Colorectal Carcinogenesis.
Mori G, Rampelli S, Orena BS, Rengucci C, De Maio G, Barbieri G, Passardi A, Casadei Gardini A, Frassineti GL, Gaiarsa S, Albertini AM, Ranzani GN, Calistri D, Pasca MR. Mori G, et al. Among authors: orena bs. Sci Rep. 2018 Jul 9;8(1):10329. doi: 10.1038/s41598-018-28671-9. Sci Rep. 2018. PMID: 29985435 Free PMC article.
Gut Microbiota Analysis in Postoperative Lynch Syndrome Patients.
Mori G, Orena BS, Cultrera I, Barbieri G, Albertini AM, Ranzani GN, Carnevali I, Tibiletti MG, Pasca MR. Mori G, et al. Among authors: orena bs. Front Microbiol. 2019 Jul 30;10:1746. doi: 10.3389/fmicb.2019.01746. eCollection 2019. Front Microbiol. 2019. PMID: 31417532 Free PMC article.
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug.
Mori G, Orena BS, Chiarelli LR, Degiacomi G, Riabova O, Sammartino JC, Makarov V, Riccardi G, Pasca MR. Mori G, et al. Among authors: orena bs. Front Microbiol. 2020 Feb 25;11:292. doi: 10.3389/fmicb.2020.00292. eCollection 2020. Front Microbiol. 2020. PMID: 32158439 Free PMC article.
Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over.
Alicandro G, Daccó V, Cariani L, Contarini M, Morlacchi LC, Rosazza C, Sciarrabba CS, Ferraro F, Lanfranchi C, Orena BS, Gramegna A, Blasi F, Colombo C. Alicandro G, et al. Among authors: orena bs. J Cyst Fibros. 2022 May;21(3):e173-e175. doi: 10.1016/j.jcf.2022.02.009. Epub 2022 Feb 16. J Cyst Fibros. 2022. PMID: 35256306 Free PMC article. No abstract available.
New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053.
Chiarelli LR, Salina EG, Mori G, Azhikina T, Riabova O, Lepioshkin A, Grigorov A, Forbak M, Madacki J, Orena BS, Manfredi M, Gosetti F, Buzzi A, Degiacomi G, Sammartino JC, Marengo E, Korduláková J, Riccardi G, Mikušová K, Makarov V, Pasca MR. Chiarelli LR, et al. Among authors: orena bs. ACS Infect Dis. 2020 Feb 14;6(2):313-323. doi: 10.1021/acsinfecdis.9b00388. Epub 2019 Dec 2. ACS Infect Dis. 2020. PMID: 31729215
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK.
Chiarelli LR, Mori G, Orena BS, Esposito M, Lane T, de Jesus Lopes Ribeiro AL, Degiacomi G, Zemanová J, Szádocka S, Huszár S, Palčeková Z, Manfredi M, Gosetti F, Lelièvre J, Ballell L, Kazakova E, Makarov V, Marengo E, Mikusova K, Cole ST, Riccardi G, Ekins S, Pasca MR. Chiarelli LR, et al. Among authors: orena bs. Sci Rep. 2018 Feb 16;8(1):3187. doi: 10.1038/s41598-018-21614-4. Sci Rep. 2018. PMID: 29453370 Free PMC article.
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy.
Alicandro G, Daccó V, Cariani L, Contarini M, Morlacchi LC, Rosazza C, Sciarrabba CS, Ferraro F, Orena BS, Gramegna A, Blasi F, Colombo C. Alicandro G, et al. Among authors: orena bs. J Cyst Fibros. 2022 Mar;21(2):e113-e116. doi: 10.1016/j.jcf.2021.12.011. Epub 2021 Dec 13. J Cyst Fibros. 2022. PMID: 34949558 Free PMC article.
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
Mori G, Orena BS, Franch C, Mitchenall LA, Godbole AA, Rodrigues L, Aguilar-Pérez C, Zemanová J, Huszár S, Forbak M, Lane TR, Sabbah M, Deboosere N, Frita R, Vandeputte A, Hoffmann E, Russo R, Connell N, Veilleux C, Jha RK, Kumar P, Freundlich JS, Brodin P, Aínsa JA, Nagaraja V, Maxwell A, Mikušová K, Pasca MR, Ekins S. Mori G, et al. Among authors: orena bs. Tuberculosis (Edinb). 2018 Sep;112:98-109. doi: 10.1016/j.tube.2018.08.004. Epub 2018 Aug 11. Tuberculosis (Edinb). 2018. PMID: 30205975
Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.
Oliveira PFM, Guidetti B, Chamayou A, André-Barrès C, Madacki J, Korduláková J, Mori G, Orena BS, Chiarelli LR, Pasca MR, Lherbet C, Carayon C, Massou S, Baron M, Baltas M. Oliveira PFM, et al. Among authors: orena bs. Molecules. 2017 Sep 1;22(9):1457. doi: 10.3390/molecules22091457. Molecules. 2017. PMID: 28862683 Free PMC article.
12 results